Surgery Doctors in Paradise Valley, AZ Accepting Medicare
5 Surgery doctors found. Showing 1 - 5
 Dr. John B Giedraitis, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6305 N Mockingbird Ln, Paradise Valley, AZ 85253 Phone: 480-985-1093 |
Brian J Deguzman, M.D. Surgery - Surgical Critical Care Medicare: Not Enrolled in Medicare Practice Location: 6443 E Chaparral Rd, Paradise Valley, AZ 85253 Phone: 602-505-8898 |
Dr. Ralph Salvador Carungi, D.O. Surgery Medicare: Not Enrolled in Medicare Practice Location: 6230 E Cheney Dr, Paradise Valley, AZ 85253 Phone: 602-680-0200 |
 Dr. Ashley Lynn Howarth, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 5410 N Scottsdale Rd Ste E200, Paradise Valley, AZ 85253 Phone: 480-535-5021 |
Dr. Henry Richard Wienke, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5334 E Palo Verde Dr, Paradise Valley, AZ 85253 Phone: 602-955-6062 Fax: 602-955-6063 |
News Archive
Many anti-malaria drugs in Africa fake or substandard, reports show
"Many of Africa's anti-malaria drugs are fake or of poor quality, weakening a crucial battle against the world's deadliest disease, a new investigation has found," GlobalPost reports, adding, "Many of the drugs - even those approved by the World Health Organization - are Chinese fakes or low-quality variants that failed quality tests, according to two new studies released today."
High school health classes fail to endorse safe sex habits
High school health classes fail to help students refuse sexual advances or endorse safe sex habits when teachers focus primarily on testing knowledge, a new study reveals.
Big win in the battle against diabetes
In newly published research scientists have revealed that they have discovered more genes linked to Type 2 Diabetes.
Study: Threatened miscarriages complicate 20% of all pregnancies
Dr Kaltum Adam, an honorary clinical research fellow at St Mary's Hospital in Manchester (UK), told the annual meeting of the European Society for Human Reproduction and Embryology that around 20% of all pregnancies were complicated by threatened miscarriage, and up to 20% of these would miscarry.
Tivozanib overall survival results announced by AVEO and Astellas
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) announced overall survival (OS) for tivozanib, an investigational agent, from the Phase 3 TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final OS analysis, as specified by the protocol, shows a median OS of 28.8 months (95% confidence interval [CI]: 22.5–NA) for tivozanib versus a median OS of 29.3 months (95% CI: 29.3–NA) for the comparator arm, sorafenib.
› Verified 4 days ago
Internal Medicine
Family Medicine
Psychiatry & Neurology
Plastic Surgery
Surgery
Radiology
Dermatology
Anesthesiology
Orthopaedic Surgery
Pediatrics
Emergency Medicine